Geography of cancer patients at Delafontaine Hospital
Part of Cancer clinical trials.
This study looks at where cancer patients at Delafontaine Hospital live. It helps doctors better understand the communities they serve.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older) being treated for cancer at Delafontaine Hospital.
- Your cancer treatment at this hospital started on or after January 1, 2020.
- Your treatment is still ongoing, or you are in follow-up care at the same hospital.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at patients’ health literacy—how well people understand and use health information—among adults receiving care for cancer. It’s mainly for people who are followed at a particular hospital and who agree to have their medical data used.
This study looks at how well a new program of supportive care (extra help for symptoms and well-being) works for people with cancer. It's open to anyone with any type or stage of cancer who has had a needs assessment.
This study looks at whether a special program focused on how you look and feel (aesthetic oncology) can help people with head and neck cancers during their treatment. You may qualify if you are getting treatment to try to cure your cancer and can speak French.
This study helps build a population-wide cancer observatory (a real-world cancer record) for people in a specific region of France. It may help researchers better understand cancer patterns and needs in the area.
This trial tracks how lung cancer is treated in France, looking at what therapies were used and how care has evolved since 2015. It may help doctors improve future treatment choices by understanding real-world care patterns.
This study collects medical information and small tissue or fluid samples from people with peritoneal (abdominal lining) cancer. It aims to better understand the disease and improve future care plans.
Hear when a new Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.